| 摘要 |
The present invention concerns new pharmaceutical agents containing (thio)carbimidinic acid derivatives of formula I. In addition the invention concerns new (thio)carbimidinic acid derivatives, processes for the production thereof and pharmaceutical agents containing these compounds. The invention concerns pharmaceutical agents containing at least one (thio)carbimidinic acid derivative of formula I as the active substance <IMG> (I), in which R denotes an aliphatic residue or an optionally substituted phenyl group or a carbocyclic group with 7-15 C atoms or a heterocyclic ring system in which the carbocycles and heterocyles can be partially or completely hydrogenated, R1 can be phenyl, phenyl C1-C6-alkyl, hetaryl or hetaryl-C1-C6-alkyl, wherein these residues can be optionally substituted once or several times, R2 denotes hydrogen, C1-C6 alkyl, C1-C6 alkoxy, cyano, amino or hydroxy X denotes oxygen, sulphur or NR2 and Y denotes oxygen or sulphur as well as tautomers, enantiomers and diastereomers and physiologically tolerated salts thereof.
|
